James Hattersley

Vice President, Corp. Business Development, Santen Incorporated

James E. Hattersley currently serves as Vice President Business Development at Santen Incorporated based in northern California.  Santen is a global pharmaceutical company focused solely on business growth strategies in ophthalmology, and on addressing serious unmet needs by invoking innovative solutions that protect and restore vision.

Before Santen, James served as SVP Business Development at Adherium - a global digital health adherence outcomes organization - where he was directly responsible for establishing Adherium's operational site and business strategy in North America in 2016 now being executed by Adherium's current management team.  Prior to Adherium, Mr. Hattersley held the position of Vice President of Business Development at Nektar Therapeutics accountable for business development, corporate strategic alliances, alliance management, and commercial partnerships for late stage clinical assets in oncology, ophthalmology, and pain management.  Before Nektar, James served for several years as Vice President of Business Development at Sun Pharmaceutical Industries directly responsible for acquisitions and strategic partnerships in North America, and out-licensing of oncology, ophthalmology, CNS, and respiratory opportunities in Japan territory.

Mr. Hattersley has over 25 years of successful leadership experience in international life sciences, with a proven track record of identifying and executing deals of significant value.  During the course of his career James has successfully completed numerous revenue-generating transactions involving SMid and large cap biotech/pharma organizations.  Mr. Hattersley earned graduate and undergraduate academic degrees in biochemistry and neurobiology, respectively, from the University of California.  In addition, James successfully completed post-graduate executive studies in financial analytics at University of Chicago GSB.


MeEt Us

View our upcoming events

View All Events